Physician profile
Roberta Schieda
NPI 1831499003
$1,403.30
in general payments reported to CMS, 2019-2025
17 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $465 · 2023: $296 · 2024: $121 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $310.78 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $224.33 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $165.98 | 2021-2024 | Xarelto |
| Amgen INC. | $146.83 | 2023-2025 | Repatha, Repatha |
| Abbott Laboratories | $125.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $122.19 | 2022 | |
| Esperion Therapeutics, INC. | $52.31 | 2021-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $37.20 | 2023-2024 | Farxiga |
| Kestra Medical Technology Services, INC. | $31.02 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.63 | 2025 | |
| Philips North America LLC | $28.20 | 2025 | Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.45 | 2025 | Jardiance |
| Recor Medical INC | $25.69 | 2025 | Paradise Ultrasound Renal Denervation System |
| Impulse Dynamics (USA) INC. | $21.20 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $20.05 | 2024 | Arcalyst |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Schieda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.